Ultrasonic Particles: An Approach for Targeted Gene Delivery
Overview
Affiliations
Gene therapy has been widely investigated for the treatment of genetic, acquired, and infectious diseases. Pioneering work utilized viral vectors; however, these are suspected of causing serious adverse events, resulting in the termination of several clinical trials. Non-viral vectors, such as lipid nanoparticles, have attracted significant interest, mainly due to their successful use in vaccines in the current COVID-19 pandemic. Although they allow safe delivery, they come with the disadvantage of off-target delivery. The application of ultrasound to ultrasound-sensitive particles allows for a direct, site-specific transfer of genetic materials into the organ/site of interest. This process, termed ultrasound-targeted gene delivery (UTGD), also increases cell membrane permeability and enhances gene uptake. This review focuses on the advances in ultrasound and the development of ultrasonic particles for UTGD across a range of diseases. Furthermore, we discuss the limitations and future perspectives of UTGD.
Harnessing stimuli-responsive biomaterials for advanced biomedical applications.
Liao Z, Liu T, Yao Z, Hu T, Ji X, Yao B Exploration (Beijing). 2025; 5(1):20230133.
PMID: 40040822 PMC: 11875454. DOI: 10.1002/EXP.20230133.
Bao H, Dai L, Wang H, Jiang T Int J Pharm X. 2024; 8:100300.
PMID: 39624342 PMC: 11609676. DOI: 10.1016/j.ijpx.2024.100300.
Vidallon M, Liu H, Lu Z, Acter S, Song Y, Baldwin C Small. 2024; 21(2):e2406019.
PMID: 39523733 PMC: 11735900. DOI: 10.1002/smll.202406019.
Vidallon M, Moon M, Liu H, Song Y, Crawford S, Teo B ACS Appl Mater Interfaces. 2024; .
PMID: 39360874 PMC: 11492166. DOI: 10.1021/acsami.4c12024.
Zhang Q, Zhu Y, Zhang G, Xue H, Ding B, Tu J Ultrason Sonochem. 2024; 110:107051.
PMID: 39232288 PMC: 11404082. DOI: 10.1016/j.ultsonch.2024.107051.